Literature DB >> 12202208

Azathioprine inhibits vaccinia virus replication in both BSC-40 and RAG cell lines acting on different stages of virus cycle.

Clarissa R A Damaso1, Marcus F Oliveira, Susana M Massarani, Nissin Moussatché.   

Abstract

In the present study we demonstrate that azathioprine (AZA) inhibits vaccinia virus (VV) replication in both BSC-40 and RAG cell lines, acting on different stages of virus cycle. In BSC-40 cells, early protein synthesis was not significantly affected, but late gene expression was severely impaired. In RAG cells all stages of gene expression were completed during synchronous infection in the presence of the drug. The onset of DNA replication was not affected in RAG cells, but a severe inhibition was observed in BSC-40 cells. Electron microscopic analysis of VV-infected RAG cells treated with AZA revealed brick-shaped particles presenting abnormal definition of the internal structure. Purified virions from AZA-treated RAG cells presented several modifications of the protein content, a lesser amount of DNA, and a lower PFU:particle ratio. Our results suggest that in VV-infected RAG cells AZA interfered with virus morphogenesis, whereas in BSC-40 cells the replicative cycle was inhibited at the DNA replication stage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202208     DOI: 10.1006/viro.2002.1534

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Biological characterization and next-generation genome sequencing of the unclassified Cotia virus SPAn232 (Poxviridae).

Authors:  Priscila P Afonso; Patrícia M Silva; Laila C Schnellrath; Desyreé M Jesus; Jianhong Hu; Yajie Yang; Rolf Renne; Marcia Attias; Richard C Condit; Nissin Moussatché; Clarissa R Damaso
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

2.  The E6 protein from vaccinia virus is required for the formation of immature virions.

Authors:  Olga Boyd; Peter C Turner; Richard W Moyer; Richard C Condit; Nissin Moussatche
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

3.  Temperature-sensitive mutant in the vaccinia virus E6 protein produce virions that are transcriptionally inactive.

Authors:  Olga Boyd; Audra L Strahl; Carson Rodeffer; Richard C Condit; Nissin Moussatche
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

4.  Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles.

Authors:  Ana Paula V Castro; Técia M U Carvalho; Nissin Moussatché; Clarissa R A Damaso
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  The vaccinia virus E8R gene product is required for formation of transcriptionally active virions.

Authors:  Sayuri E M Kato; Richard C Condit; Nissin Moussatché
Journal:  Virology       Date:  2007-07-09       Impact factor: 3.616

6.  Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus.

Authors:  Desyreé Murta Jesus; Lilian T Costa; Daniela L Gonçalves; Carlos Alberto Achete; Marcia Attias; Nissin Moussatché; Clarissa R Damaso
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

Review 7.  The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19.

Authors:  Qing Ye; Bili Wang; Ting Zhang; Jian Xu; Shiqiang Shang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-07-08       Impact factor: 4.871

8.  Accidental infection of laboratory worker with vaccinia virus.

Authors:  Nissin Moussatché; Mari Tuyama; Sayuri E M Kato; Ana Paula V Castro; Brian Njaine; Regina H Peralta; José M Peralta; Clarissa R A Damaso; Paulo F Barroso
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.